We are live on
!
Find out more
Catalyst Pharmaceutical
CPRX
CPRX
373 hedge funds and large institutions have $2.42B invested in Catalyst Pharmaceutical in 2025 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 125 increasing their positions, 127 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 45
19% more capital invested
Capital invested by funds: $2.04B → $2.42B (+$389M)
4% more funds holding
Funds holding: 360 → 373 (+13)
0.15% more ownership
Funds ownership: 84.42% → 84.57% (+0.15%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 127
7% less call options, than puts
Call options by funds: $2.02M | Put options by funds: $2.19M
Holders
373
Holders Change
+13
Holders Change %
+3.61%
% of All Funds
4.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
64
Increased
125
Reduced
127
Closed
45
Calls
$2.02M
Puts
$2.19M
Net Calls
-$164K
Net Calls Change
+$4.67M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$25.6M |
| 2 |
Morgan Stanley
New York
|
+$24.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12M |
| 4 |
State Street
Boston,
Massachusetts
|
+$11.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$11.1M |
